Transaction #6407 · Form 4 · 0001193125-25-274369
Enova International, Inc. · Stock award · Non-Qualified Stock Option (right to buy) with limited SAR
Enova International, Inc. · Transacted November 6, 2025 · Filed November 10, 2025
What does this filing report?
An SEC Form 4 filing for Enova International, Inc. records a stock award involving Non-Qualified Stock Option (right to buy) with limited SAR on November 6, 2025. The reported quantity was 20,793. The filing date is November 10, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Enova International, Inc.
- Company CIK
- 0001529864
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 20,793
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 20,793
- Ownership description
- Not reported
- SEC acceptance time
- Nov 10, 2025, 4:30 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Fisher David ↗
Chief Executive Officer · Director
CIK 0001315224
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common stock; par value $0.00001 per share
- Underlying quantity
- 20,793
- Conversion / exercise price
- 128
- Exercise date
- Not reported
- Expiration date
- November 6, 2032
Filing footnotes & remarks
- F1
- The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
- F2
- The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
- F3
- The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: November 6, 2026, November 6, 2027 and November 6, 2028.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.